ClinicalTrials HQ

Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI).

Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI).

Active, not recruiting · NCT06253923 · Registry updated 2025-07-15
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI).Brain Injuries, Traumatic, Craniocerebral Trauma, brain disorder, brain injury, central nervous system disorder, injury, nervous system disorder, nervous system injuryActive, not recruitingPhase 22025-07-15NCT06253923

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Duke Clinical Research Institute13
SHINKEI Therapeutics, Inc1

13 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Barnes Jewish HospitalSt LouisUnited States16
Department of Neurology, Duke University School of MedicineDurhamUnited States1
Hackensack Meridian Health Jersey Shore University Medical CenterNeptune CityUnited States4
Los Angeles General Medical CenterLos AngelesUnited States179
Maine Medical CenterPortlandUnited States31
McGovern Medical School, University of Texas Health Science CenterHoustonUnited States1
Medical College of WisconsinMilwaukeeUnited States483
Penn Presbyterian Medical CenterPhiladelphiaUnited States44
Tampa General HospitalTampaUnited States128
UC Davis Medical CenterSacramentoUnited States63
UF Health Heart and Vascular HospitalGainesvilleUnited States2
University of New Mexico HospitalAlbuquerqueUnited States10
Wayne State UniversityDetroitUnited States26